Very Early FDG-PET/CT-response Adapted Therapy for Advanced Hodgkin Lymphoma (H11)
Clinical trial NCT01652261 · WITHDRAWN
Trial details
- NCT number
- NCT01652261
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2014-10-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.